There is no cure for Huntington's disease, but a new gene treatment is the first to significantly slow the symptoms in human ...
California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.
Gov. Gavin Newsom announced Thursday that the state would provide insulin shots for $11, far below market prices.
Gov. Gavin Newsom says California will begin selling affordable insulin under its own label on Jan. 1, nearly three years ...
The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.
The first CalRx product will be long-acting glargine insulin pens, the generic version of Lantus, used to regulate blood ...
The U.S. Food and Drug Administration removed the Risk Evaluation and Mitigation Strategies (REMS) program for Caprelsa (vandetanib), a thyroid cancer medication manufactured by Sanofi SA’s (NASDAQ: ...
Needle-Free Compounded Semaglutide and Tirzepatide Tablets Offer Physician-Supervised, At-Home GLP-1 Treatment Access Through ...
Getting enough sleep, staying physically active, and managing stress can improve overall health and wellness and boost insulin sensitivity. When it comes to your diet, increasing soluble fiber intake, ...
Hundreds of residents from remote Alaska Native villages are being airlifted after a storm battered their communities. The ...
Officials say one of the “most significant” airlifts in Alaskan history is underway following a devastating typhoon. Hundreds ...
A federal judge has ordered the Trump administration to restore $500 million in federal grant funding that it froze at the University of California, Los Angeles. US District Judge Rita Lin in San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback